Remove Contract Manufacturing Remove Packaging Remove Pharma Companies Remove Vaccination
article thumbnail

Injectable opportunities for CMOs despite internal capacity of big pharma sponsors

Pharmaceutical Technology

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing-April

Pharmaceutical Technology

Pharmaceutical Technology looks at drugs and biologics with recent regulatory verdicts that will likely impact manufacturing volumes. In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). Covid-19 vaccines stay in the spotlight.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Local production of Sputnik V in Brazil was started in January 2021.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

US President Joe Biden has gained approval from Congress for a new package of aid worth $40bn, and the US government announced last month that it plans to provide an additional $1bn in security assistance to Ukraine. million vaccine doses upon EMA authorisation. Roszdravnadzor was founded by Vladimir Putin in 2004.